Biotech Acquisition Co Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biotech Acquisition Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2022.
  • Biotech Acquisition Co Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was $1.26M.
  • Biotech Acquisition Co Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was $11M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $1.26M +$1.27M Sep 30, 2022 10-Q 2022-11-22
Q2 2022 $9.38M +$14.5M Jun 30, 2022 10-Q 2022-11-22
Q1 2022 $4.68M +$2.13M +83.7% Mar 31, 2022 10-Q 2022-11-22
Q4 2021 -$4.34M -$4.33M Dec 31, 2021 10-K 2022-03-08
Q3 2021 -$5K* $0 Sep 30, 2021 10-Q 2021-11-17
Q3 2021 $2.94M +$2.95M Sep 30, 2021 10-Q 2022-11-22
Q2 2021 -$5.07M Jun 30, 2021 10-Q 2022-11-22
Q1 2021 $2.55M Mar 31, 2021 10-Q 2022-11-22
Q4 2020 -$5K* Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$5K* Sep 30, 2020 10-Q 2021-11-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.